The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl
- PMID: 8540464
- DOI: 10.1016/s0002-9149(97)89140-0
The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl
Abstract
This study demonstrated that pravastatin 20 mg once daily significantly lowered total cholesterol (by 19%) and LDL cholesterol by 25%.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
